Platinum-Resistant Urothelial Carcinoma

Platinum-Resistant Urothelial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04936230	Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer	terminated	Phase 2	1	National Cancer Institute (NCI)NIH	1	Aug 17, 2025	clinicaltrials
NCT05052372	Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib	terminated	—	2	xCuresINDUSTRY	1	Dec 22, 2022	clinicaltrials